Back
Theravance Biopharma Vs. Pro-Dex Industry Stock Comparison
Sell
35
TBPH
Theravance Biopharma
Last Price:
$9.25
Seasonality Move:
-1.36%
Buy
68
PDEX
Pro-Dex
Last Price:
$51.49
Seasonality Move:
10.27%
Sell
35
Theravance Biopharma (TBPH)
is a Sell
Is Theravance Biopharma a Buy, Sell or Hold?
-
The current Theravance Biopharma [TBPH] share price is $9.25. The Score for TBPH is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
-
TBPH is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
TBPH Stock Price Chart
What is Theravance Biopharma's stock price today?
-
The Theravance Biopharma share price today is $9.25Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TBPH is experiencing slight buying pressure.
TBPH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.05 | Sell |
Relative Strength Index (14 RSI): | 41.7 | Sell |
Chaikin Money Flow: | 61795 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (9.43 - 9.95) | Sell |
Bollinger Bands (100): | (8.08 - 9.5) | Buy |
PDEX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.3 | Buy |
Relative Strength Index (14 RSI): | 55.69 | Buy |
Chaikin Money Flow: | -20256 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (46.32 - 52.22) | Buy |
Bollinger Bands (100): | (24.46 - 47.06) | Buy |
TBPH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 9.42 | Sell |
20-day SMA: | 9.68 | Sell |
50-day SMA: | 9.37 | Sell |
200-day SMA: | 8.94 | Buy |
8-day EMA: | 9.39 | Sell |
20-day EMA: | 9.53 | Sell |
50-day EMA: | 9.36 | Sell |
200-day EMA: | 9.1 | Buy |
PDEX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 49.35 | Buy |
20-day SMA: | 48.53 | Buy |
50-day SMA: | 45.81 | Buy |
200-day SMA: | 27.28 | Buy |
8-day EMA: | 50.13 | Buy |
20-day EMA: | 48.86 | Buy |
50-day EMA: | 44.85 | Buy |
200-day EMA: | 31.31 | Buy |
Theravance Biopharma Earnings Growth & TBPH Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.08 per share, and an increase next year of $0.07 per share.
Pro-Dex Earnings Growth & PDEX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.50 per share, and an increase next year of $0.06 per share.
Theravance Biopharma Technical Analysis
Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Pro-Dex Technical Analysis
Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |